NVRVF yields 2000.00% · JNJ yields 2.13%● Live data
📍 NVRVF pulled ahead of the other in Year 1
Combined, NVRVF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NVRVF + JNJ for your $10,000?
Novra Technologies Inc., together with its subsidiaries, provides hardware, software, and services for the distribution of satellite data in Canada, North America, Central America, South America, Europe, the Middle East, Africa, East Asia, South Asia, Southeast Asia, and Oceania. The company offers video distribution products and systems for the provision of end-to-end solutions to traditional and non-traditional video networks; infrastructure solutions for broadcast radio networks, including uplink and receive site equipment, as well as network management, encryption, and targeted regionalization/ad insertion options; and data distribution for hardware infrastructure, as well as content distribution network software solution. It also provides digital cinema network infrastructure and services; appliances for cinemas; decoders for live events; alternative content in 2D and 3D; digital cinema distribution software solutions; and DVB and ATSC compliant receivers for the broadband communications network market. The company was founded in 2000 and is headquartered in Winnipeg, Canada.
Full NVRVF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.